7048

    524669

    HESTERBIO

    No Data Available

    Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

    HESTER BIOSCIENCES LTD Share Price Today

    HESTER BIOSCIENCES LTD is currently trading at ₹2410.2, down by ₹48.3 from the previous close. The stock touched an intraday high of ₹2500.80 and a low of ₹2401.00 during the latest trading session. Over the past one year, HESTER BIOSCIENCES LTD has delivered a return of 23.73%, while the stock has gained 13.37% in the last one month.

    HESTER BIOSCIENCES LTD performance

    Today’s low Today’s high
    ₹ 2401.00 ₹ 2500.80
    ₹ 2417.90
    52 week low 52 week high
    ₹ 1239.30 ₹ 2683.60
    ₹ 2417.90
    Open Price ₹ 2484.70
    Prev. Close ₹ 2458.50
    Volume (Shares) 5928.00
    Total traded value ₹ 143.33
    Upper Circuit ₹ 2950.20
    Lower Circuit ₹ 1966.80
    info

    Investment Returns

    Over 1 Month 13.37% Over 3 Months 48.26% Over 6 Months 62.86% Over 1 Year 23.73%
    Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

    HESTER BIOSCIENCES LTD fundamentals


    • Market cap (Cr) 2,056.90
    • P/E Ratio (TTM) 35.35
    • Beta 0.73
    • Book Value / share 452.78
    • Return on equity 14.39%
    • EPS (TTM) 63.10
    • Dividend yield 0.45%
    • Net profit/quarter (Cr) 14.71
    info icon alternate text
    • Market cap (Cr) 2,057.90
    • P/E Ratio (TTM) 35.35
    • Beta 0.71
    • Book Value / share 452.78
    • Return on equity 14.39%
    • EPS (TTM) 63.10
    • Dividend yield 0.45%
    • Net profit/quarter (Cr) 14.71
    info icon alternate text

    HESTER BIOSCIENCES LTD Financials

    Open financial information
    Revenue
    Net income
    Particulars JUN 2026 (Values in Cr)
    Revenue 72.66
    Operating Expense 54.58
    Net Profit 14.71
    Net Profit Margin (%) 20.24
    Earnings Per Share (EPS) 17.29
    EBITDA 26.03
    Effective Tax Rate (%) 25.51
    Particulars MAR 2026 (Values in Cr)
    Revenue 93.71
    Operating Expense 70.01
    Net Profit 26.38
    Net Profit Margin (%) 28.15
    Earnings Per Share (EPS) 31.01
    EBITDA 42.63
    Effective Tax Rate (%) 24.34
    Particulars DEC 2025 (Values in Cr)
    Revenue 70.35
    Operating Expense 56.75
    Net Profit 10.67
    Net Profit Margin (%) 15.16
    Earnings Per Share (EPS) 12.54
    EBITDA 17.75
    Effective Tax Rate (%) 27.11
    Particulars SEP 2025 (Values in Cr)
    Revenue 64.58
    Operating Expense 56.17
    Net Profit 7.21
    Net Profit Margin (%) 11.16
    Earnings Per Share (EPS) 8.48
    EBITDA 13.35
    Effective Tax Rate (%) 27.02
    Particulars JUN 2025 (Values in Cr)
    Revenue 63.49
    Operating Expense 54.15
    Net Profit 7.84
    Net Profit Margin (%) 12.34
    Earnings Per Share (EPS) 9.21
    EBITDA 13.36
    Effective Tax Rate (%) 23.80
    Particulars MAR 2026 (Values in Cr)
    Revenue 292.14
    Operating Expense 237.08
    Net Profit 52.10
    Net Profit Margin (%) 17.83
    Earnings Per Share (EPS) 61.24
    EBITDA 87.10
    Effective Tax Rate (%) 25.22
    Particulars MAR 2025 (Values in Cr)
    Revenue 286.47
    Operating Expense 249.47
    Net Profit 31.84
    Net Profit Margin (%) 11.11
    Earnings Per Share (EPS) 37.43
    EBITDA 55.70
    Effective Tax Rate (%) 23.75
    Particulars MAR 2024 (Values in Cr)
    Revenue 285.16
    Operating Expense 252.68
    Net Profit 27.16
    Net Profit Margin (%) 9.52
    Earnings Per Share (EPS) 31.93
    EBITDA 51.59
    Effective Tax Rate (%) 26.05
    Particulars MAR 2023 (Values in Cr)
    Revenue 254.00
    Operating Expense 215.40
    Net Profit 32.34
    Net Profit Margin (%) 12.73
    Earnings Per Share (EPS) 38.02
    EBITDA 60.21
    Effective Tax Rate (%) 26.36
    Particulars MAR 2022 (Values in Cr)
    Revenue 219.35
    Operating Expense 170.75
    Net Profit 39.52
    Net Profit Margin (%) 18.01
    Earnings Per Share (EPS) 46.45
    EBITDA 65.22
    Effective Tax Rate (%) 25.79
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 423.46
    ROE % 17.04
    ROCE % 14.56
    Total Debt to Total Equity 0.60
    EBITDA Margin 31.76
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 369.41
    ROE % 9.51
    ROCE % 8.86
    Total Debt to Total Equity 0.76
    EBITDA Margin 22.20
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 343.00
    ROE % 7.41
    ROCE % 8.74
    Total Debt to Total Equity 0.91
    EBITDA Margin 22.63
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 328.82
    ROE % 10.39
    ROCE % 9.01
    Total Debt to Total Equity 0.93
    EBITDA Margin 26.37
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 305.61
    ROE % 16.17
    ROCE % 13.29
    Total Debt to Total Equity 0.68
    EBITDA Margin 31.55
    Particulars MAR 2026 (Values in Cr)
    Book Value / Share 452.78
    ROE % 14.39
    ROCE % 15.28
    Total Debt to Total Equity 0.25
    EBITDA Margin 29.81
    Particulars MAR 2025 (Values in Cr)
    Book Value / Share 398.60
    ROE % 9.77
    ROCE % 9.47
    Total Debt to Total Equity 0.36
    EBITDA Margin 19.45
    Particulars MAR 2024 (Values in Cr)
    Book Value / Share 367.59
    ROE % 8.98
    ROCE % 8.51
    Total Debt to Total Equity 0.49
    EBITDA Margin 18.10
    Particulars MAR 2023 (Values in Cr)
    Book Value / Share 343.70
    ROE % 11.53
    ROCE % 11.52
    Total Debt to Total Equity 0.51
    EBITDA Margin 23.70
    Particulars MAR 2022 (Values in Cr)
    Book Value / Share 315.54
    ROE % 15.62
    ROCE % 17.26
    Total Debt to Total Equity 0.27
    EBITDA Margin 29.74
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 6.53
    Total Assets 677.94
    Total Liabilities 677.94
    Total Equity 367.78
    Share Outstanding 0
    Price to Book Ratio 2.79
    Return on Assets (%) 8.20
    Return on Capital (%) 10.01
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 7.21
    Total Assets 653.38
    Total Liabilities 653.38
    Total Equity 326.65
    Share Outstanding 0
    Price to Book Ratio 3.15
    Return on Assets (%) 4.20
    Return on Capital (%) 5.14
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 15.30
    Total Assets 662.34
    Total Liabilities 662.34
    Total Equity 302.87
    Share Outstanding 0
    Price to Book Ratio 3.78
    Return on Assets (%) 2.85
    Return on Capital (%) 3.49
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 14.81
    Total Assets 669.96
    Total Liabilities 669.96
    Total Equity 288.54
    Share Outstanding 0
    Price to Book Ratio 4.42
    Return on Assets (%) 3.97
    Return on Capital (%) 4.78
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 25.20
    Total Assets 562.16
    Total Liabilities 562.16
    Total Equity 267.39
    Share Outstanding 0
    Price to Book Ratio 8.61
    Return on Assets (%) 6.99
    Return on Capital (%) 8.03
    Particulars MAR 2026 (Values in Cr)
    Cash & Short Term Investments 4.56
    Total Assets 557.34
    Total Liabilities 557.34
    Total Equity 385.18
    Share Outstanding 0
    Price to Book Ratio 2.79
    Return on Assets (%) 9.34
    Return on Capital (%) 11.33
    Particulars MAR 2025 (Values in Cr)
    Cash & Short Term Investments 2.17
    Total Assets 545.99
    Total Liabilities 545.99
    Total Equity 339.08
    Share Outstanding 0
    Price to Book Ratio 3.15
    Return on Assets (%) 5.83
    Return on Capital (%) 7.18
    Particulars MAR 2024 (Values in Cr)
    Cash & Short Term Investments 4.96
    Total Assets 549.54
    Total Liabilities 549.54
    Total Equity 312.71
    Share Outstanding 0
    Price to Book Ratio 3.78
    Return on Assets (%) 4.94
    Return on Capital (%) 6.09
    Particulars MAR 2023 (Values in Cr)
    Cash & Short Term Investments 5.96
    Total Assets 545.81
    Total Liabilities 545.81
    Total Equity 292.38
    Share Outstanding 0
    Price to Book Ratio 4.42
    Return on Assets (%) 5.92
    Return on Capital (%) 7.08
    Particulars MAR 2022 (Values in Cr)
    Cash & Short Term Investments 1.98
    Total Assets 424.44
    Total Liabilities 424.44
    Total Equity 268.43
    Share Outstanding 0
    Price to Book Ratio 8.61
    Return on Assets (%) 9.31
    Return on Capital (%) 10.12
    Particulars MAR 2026 (Values in Cr)
    Net Income 75.83
    Cash from Operations 78.26
    Cash from Investing -2.86
    Cash from Financing -48.79
    Net change in Cash -2.82
    Free Cash Flow 96.09
    Particulars MAR 2025 (Values in Cr)
    Net Income 39.57
    Cash from Operations 75.98
    Cash from Investing -19.00
    Cash from Financing -51.71
    Net change in Cash -6.72
    Free Cash Flow 96.57
    Particulars MAR 2024 (Values in Cr)
    Net Income 31.95
    Cash from Operations 59.84
    Cash from Investing -22.60
    Cash from Financing -26.09
    Net change in Cash -0.35
    Free Cash Flow 84.24
    Particulars MAR 2023 (Values in Cr)
    Net Income 40.15
    Cash from Operations 31.70
    Cash from Investing -76.99
    Cash from Financing 41.75
    Net change in Cash -11.59
    Free Cash Flow 109.46
    Particulars MAR 2022 (Values in Cr)
    Net Income 53.50
    Cash from Operations 25.82
    Cash from Investing -116.58
    Cash from Financing 111.53
    Net change in Cash 3.48
    Free Cash Flow 121.53
    Particulars MAR 2026 (Values in Cr)
    Net Income 69.68
    Cash from Operations 64.41
    Cash from Investing -2.36
    Cash from Financing -48.31
    Net change in Cash 0.24
    Free Cash Flow 81.73
    Particulars MAR 2025 (Values in Cr)
    Net Income 41.76
    Cash from Operations 73.89
    Cash from Investing -19.04
    Cash from Financing -46.35
    Net change in Cash -1.42
    Free Cash Flow 94.52
    Particulars MAR 2024 (Values in Cr)
    Net Income 36.73
    Cash from Operations 53.89
    Cash from Investing -20.58
    Cash from Financing -24.12
    Net change in Cash -1.84
    Free Cash Flow 76.26
    Particulars MAR 2023 (Values in Cr)
    Net Income 43.92
    Cash from Operations 41.42
    Cash from Investing -71.96
    Cash from Financing 41.37
    Net change in Cash 2.77
    Free Cash Flow 114.07
    Particulars MAR 2022 (Values in Cr)
    Net Income 53.25
    Cash from Operations 32.34
    Cash from Investing -110.58
    Cash from Financing 94.96
    Net change in Cash 0.28
    Free Cash Flow 123.01
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.93 18.23 2.12 336.65 23.12 45.50
    BLISS GVS PHARMA LTD 493.60 39.74 4.39 5244.20 118.35 552.90
    CIPLA LTD 1475.00 33.30 3.46 119157.18 1165.55 1672.20
    FERMENTA BIOTECH LIMITED 551.60 25.80 3.99 1623.41 256.40 564.50
    Company Name Price P/E P/B Market Cap 52 Week Low 52 Week High
    AMBALAL SARABHAI ENT L 43.93 30.72 5.65 336.65 23.12 45.50
    AMRUTANJAN HEALTH CARE LTD. 519.90 23.30 4.05 1503.06 490.00 789.95
    ASTRAZENECA PHARMA INDIA LTD. 8091.35 105.74 23.17 20228.38 7630.00 9850.00
    BLISS GVS PHARMA LTD 493.60 53.42 4.53 5244.20 118.35 552.90

    HESTER BIOSCIENCES LTD shareholding pattern

    Holding
    45.95%
    53.73%
    0.31%
    Name Shares Category
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)
    (%)

    News

    Left Arrow
    Right Arrow

    HESTER BIOSCIENCES LTD Technicals Summary

    2417.90 -1.65 redarrow
    red-green-graph indicator
    7 Bearish
    9 Bullish
    • 5 Days 2458.70
    • 26 Days 2372.10
    • 10 Days 2453.80
    • 50 Days 2229.10
    • 12 Days 2447.30
    • 100 Days 2028.00
    • 20 Days 2407.50
    • 200 Days 1897.70
    2446.90 PIVOT
    First Support 2423.80 First Resistance 2481.60 Second Support 2389.10 Second Resistance 2504.70 Third Support 2366.00 Third Resistance 2539.40
    RSI 57.48 ADX 48.81 MACD 75.13 Williams % R -58.83 Commodity Channel Index (CCI) 10.25
    Date 2026-08-06 Week 7984.00 Same Day 1505.00 Month 13287.00
    1 Year 0.73 3 Year 0.76
    Over 1 Month
    13.37% down
    Over 1 Year
    23.73% down
    Over 3 Months
    48.26% down
    Over 3 Years
    12.93% down
    Over 6 Months
    62.86% down
    Over 5 Years
    0.93% down

    HESTER BIOSCIENCES LTD Corporate Actions

    Dividend date Dividend amount Dividend type Record date Instrument type
    14 Jul 2026 11.0 Final 14 Jul 2026 Equity shares
    06 Aug 2025 7.0 Final 06 Aug 2025 Equity shares
    22 Aug 2024 6.0 Final 23 Aug 2024 Equity shares
    13 Sep 2023 8.0 Final 14 Sep 2023 Equity shares
    11 Aug 2022 10.0 Final 12 Aug 2022 Equity shares
    05 Aug 2021 10.0 Final 07 Aug 2021 Equity shares
    27 Aug 2020 6.6 Final 29 Aug 2020 Equity shares
    18 Jul 2019 7.0 Final 20 Jul 2019 Equity shares
    09 Nov 2018 2.0 Interim 2 12 Nov 2018 Equity shares
    30 Aug 2018 2.0 Interim 1 31 Aug 2018 Equity shares
    02 Aug 2018 6.0 Final 04 Aug 2018 Equity shares
    16 Nov 2017 4.0 Interim 17 Nov 2017 Equity shares
    20 Jul 2017 2.3 Final 22 Jul 2017 Equity shares
    03 Nov 2016 3.0 Interim 04 Nov 2016 Equity shares
    21 Jul 2016 1.1 Final 23 Jul 2016 Equity shares
    17 Mar 2016 3.0 Interim 18 Mar 2016 Equity shares
    10 Sep 2015 3.1 Final 12 Sep 2015 Equity shares
    18 Sep 2014 2.0 Final 20 Sep 2014 Equity shares
    07 Aug 2013 2.0 Final 10 Aug 2013 Equity shares
    27 Aug 2012 1.0 Final 28 Aug 2012 Equity shares
    25 Aug 2011 3.5 Final 27 Aug 2011 Equity shares
    22 Jul 2010 3.0 Final 24 Jul 2010 Equity shares
    13 Aug 2009 2.5 Final 15 Aug 2009 Equity shares
    21 Aug 2008 2.5 Final 23 Aug 2008 Equity shares
    06 Sep 2007 2.0 Final 08 Sep 2007 Equity shares
    06 Jun 2005 0.0 Final 08 Jun 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    29 Sep 2012 27 Sep 2012 1:2
    Dividend date Dividend amount Dividend type Record date Instrument type
    14 Jul 2026 11.0 Final 14 Jul 2026 Equity shares
    06 Aug 2025 7.0 Final 06 Aug 2025 Equity shares
    22 Aug 2024 6.0 Final 23 Aug 2024 Equity shares
    13 Sep 2023 8.0 Final 14 Sep 2023 Equity shares
    11 Aug 2022 10.0 Final 12 Aug 2022 Equity shares
    05 Aug 2021 10.0 Final 07 Aug 2021 Equity shares
    27 Aug 2020 6.6 Final 29 Aug 2020 Equity shares
    18 Jul 2019 7.0 Final 20 Jul 2019 Equity shares
    09 Nov 2018 2.0 Interim 2 12 Nov 2018 Equity shares
    30 Aug 2018 2.0 Interim 1 31 Aug 2018 Equity shares
    02 Aug 2018 6.0 Final 04 Aug 2018 Equity shares
    16 Nov 2017 4.0 Interim 17 Nov 2017 Equity shares
    20 Jul 2017 2.3 Final 22 Jul 2017 Equity shares
    03 Nov 2016 3.0 Interim 04 Nov 2016 Equity shares
    21 Jul 2016 1.1 Final 23 Jul 2016 Equity shares
    17 Mar 2016 3.0 Interim 18 Mar 2016 Equity shares
    10 Sep 2015 3.1 Final 12 Sep 2015 Equity shares
    18 Sep 2014 2.0 Final 20 Sep 2014 Equity shares
    07 Aug 2013 2.0 Final 10 Aug 2013 Equity shares
    27 Aug 2012 1.0 Final 28 Aug 2012 Equity shares
    25 Aug 2011 3.5 Final 27 Aug 2011 Equity shares
    22 Jul 2010 3.0 Final 24 Jul 2010 Equity shares
    13 Aug 2009 2.5 Final 15 Aug 2009 Equity shares
    21 Aug 2008 2.5 Final 23 Aug 2008 Equity shares
    06 Sep 2007 2.0 Final 08 Sep 2007 Equity shares
    06 Jun 2005 0.0 Final 08 Jun 2005 Equity shares
    Ex-Date Ex-Bonus Ratio
    29 Sep 2012 27 Sep 2012 1:2

    Top Gainers

    Top Losers

    Trade stocks with ease

    Sign-in to trade with your demat account, or set up a new demat account for free

    Board Of Directors

    Similar stocks

    Frequently Asked Questions

    What is the Current Share Price of Hester Biosciences Ltd?

    Answer Field

    Hester Biosciences Ltd share price is for NSE ₹ 2,410.20 & for BSE ₹ 2,411.10 as on Aug 07 2026 03:29 PM.

    What is the Market Cap of Hester Biosciences Ltd Share?

    Answer Field

    The market cap of Hester Biosciences Ltd for NSE ₹ 0.00 & for BSE ₹ 0.00 as on Aug 07 2026 03:29 PM.

    What is the 52 Week High and Low of Hester Biosciences Ltd?

    Answer Field

    The 52 Week High and Low of Hester Biosciences Ltd for NSE is ₹ 2,683.60 and ₹ 1,239.30 and for BSE is ₹ 2,669.00 and ₹ 1,250.95.

    What is 1 year return for Hester Biosciences Ltd?

    Answer Field

    The 1 year returns on the stock has been 23.73%.

    What is the P/E Ratio of Hester Biosciences Ltd Share?

    Answer Field

    As on Aug 07 2026 03:29 PM the price-to-earnings (PE) ratio for Hester Biosciences Ltd share is 35.35.

    What is the PB ratio of Hester Biosciences Ltd Share?

    Answer Field

    As on Aug 07 2026 03:29 PM, the price-to-book (PB) ratio for Hester Biosciences Ltd share is 452.78.

    How to Buy Hester Biosciences Ltd Share?

    Answer Field

    You can trade in Hester Biosciences Ltd shares with Bajaj Broking by opening a demat account.

    How to Buy Hester Biosciences Ltd Share on Bajaj Broking App?

    Answer Field

    To buy Hester Biosciences Ltd shares on the Bajaj Broking app, follow these steps:

    1. Login to the Bajaj Broking App

    2. Click on the Search Icon

    3. Search “Hester Biosciences Ltd”

    4. Click on the BUY icon

    5. Place a buy order specifying the desired quantity of shares.

    6. Click BUY again to complete the purchase

    No results found

    close-img
    Authorise with OTP
    Enter the 4-Digit OTP sent to
    edit
    OTP expires in 00:59

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |

    Open Your Free Demat Account

    Enjoy low brokerage on delivery trades

    +91

    |